- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/60 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 213/60
Total number of patents in this class: 100
10-year publication summary
|
1
|
4
|
3
|
8
|
4
|
2
|
6
|
2
|
8
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Syngenta Participations AG | 1730 |
4 |
| Bayer Pharma AG | 1048 |
4 |
| BeiGene, Ltd. | 292 |
4 |
| BASF SE | 21098 |
3 |
| Bayer Cropscience AG | 1983 |
3 |
| The Brigham and Women's Hospital, Inc. | 2227 |
3 |
| H. Lundbeck A/S | 1237 |
3 |
| Bristol-myers Squibb Company | 4826 |
2 |
| Merck Sharp & Dohme Corp. | 2189 |
2 |
| Battelle Memorial Institute | 2513 |
2 |
| Beijing Yiling Bioengineering Co., Ltd. | 3 |
2 |
| Kyoto University | 2857 |
2 |
| Medshine Discovery Inc. | 595 |
2 |
| Nihon Medi-physics Co., Ltd. | 175 |
2 |
| sanofi-aventis | 346 |
2 |
| Merck Sharp & Dohme LLC | 3732 |
2 |
| Soter Biopharma Pte. Ltd. | 11 |
2 |
| F. Hoffmann-La Roche AG | 7937 |
1 |
| The Regents of the University of California | 20303 |
1 |
| Genentech, Inc. | 4016 |
1 |
| Other owners | 53 |